Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs ...
Axios Sneak Peek on MSN12m
Ozempic maker's CEO blames insurance companies for weight-loss drug pricesThe chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss ...
A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...
WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo ...
U.S. Senator Bernie Sanders announced commitments from all major pharmacy benefit managers (PBMs) to expand coverage of Novo Nordisk's diabetes and weight-loss drugs, Ozempic and Wegovy, if the ...
With the presidential election just over a month away, voters will have another debate left to witness, this time between the two vice presidential candidates.
Novo Nordisk's CEO, Lars Fruergaard Jørgensen, faced tough questions on Capitol Hill Tuesday as lawmakers pressed the company ...
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback